DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Verastem, Inc. (NASDAQ: VSTM)

7.06 -0.06 (-0.84%)

Quote as of

company name or ticker

Recent Quotes

VSTM $7.06 -0.84%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.12
Previous Close $7.12
Daily Range $6.90 - $7.13
52-Week Range $6.78 - $12.35
Market Cap $257.9M
P/E Ratio -3.50
Dividend (Yield) $0.00 (0.0%)
Volume 310,790
Average Daily Volume 323,935
Current FY EPS -$1.81




Drug Makers

Verastem, Inc. (VSTM) Description

Verastem Inc is a biopharmaceutical company focused on discovering and developing proprietary small molecule drugs targeting cancer stem cells along with proprietary companion diagnostics. Website:

News & Commentary

Did Researchers Just Discover the Cause of Pancreatic Cancer?

Pancreatic cancer is the fourth-leading cause of cancer-related death, but researchers may have moved one step closer to discovering a cure this past week.

Fly Watch: Biotech Sector Events To Watch For This Summer

Verastem (VSTM) Shares March Higher, Can It Continue? - Tale of the Tape

Verastem (VSTM) Shares March Higher, Can It Continue? - Tale of the Tape

Find the Best Stocks to Invest in with This No. 1 Buy Signal

Novartis, Verastem & Cepheid Making Biotech Headlines On Friday

3 Biotech Stocks You Won't Want To Miss In 2015

Thursday 1/29 Insider Buying Report: VSTM, OKSB

The Absurdity of Flex Pharma IPO: 2 Spices and a Veg Net $86M

Recent Offering Provides Great Opportunity To Buy Verastem Before Significant 2015 Catalysts

3 Biotech IPOs Debuting This Week

See More VSTM News...